Pradaxa regulatory update

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 20 to discuss an NDA from Boehringer for Pradaxa dabigatran to prevent stroke in patients with atrial fibrillation (AF). The ...